Risk of central nervous system demyelinating attack or optic neuritis recurrence after pediatric optic neuritis in Korea

被引:2
|
作者
Moon, Yeji [1 ]
Park, Kyung-Ah [2 ]
Han, Jinu [3 ]
Hwang, Jeong-Min [4 ]
Kim, Seong-Joon [5 ]
Han, Sueng-Han [6 ]
Lee, Byung Joo [1 ]
Kang, Min Chae [2 ]
Goh, Yong Hyu [2 ]
Lim, Byung Chan [7 ]
Yang, Hee Kyung [4 ]
Jung, Jae Ho [5 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Ophthalmol,Inst Vis Res, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Coll Med, 82 Gumi Ro, 173 Beon Gil, Seongnam Si 13620, Gyeonggi Do, South Korea
[5] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Ophthalmol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[6] Yonsei Univ, Coll Med, Severance Hosp, Dept Ophthalmol,Inst Vis Res, Seoul, South Korea
[7] Seoul Natl Univ, Coll Med, Childrens Hosp, Dept Pediat, Seoul, South Korea
关键词
Pediatric optic neuritis; Aquaporin-4 immunoglobulin G; Neuromyelitis optica spectrum disorder; Myelin oligodendrocyte glycoprotein antibody; Multiple sclerosis; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MULTIPLE-SCLEROSIS; CLINICAL-FEATURES; ANTIBODIES; MRI; ABNORMALITIES; SPECTRUM; OUTCOMES;
D O I
10.1007/s10072-023-07125-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose To investigate the rate of development of symptomatic central nervous system (CNS) demyelinating attacks or recurrent optic neuritis (ON) after the first episode of ON and its risk factors for Korean pediatric patients.Methods This multicenter retrospective cohort study included the patients under 18 years of age (n=132) diagnosed with ON without previous or simultaneous CNS demyelinating diseases. We obtained the clinical data including the results of neuro-ophthalmological examinations, magnetic resonance images (MRIs), antibody assays, and laboratory tests. We investigated the chronological course of demyelinating disease with respect to the occurrence of neurological symptoms and/or signs, and calculated the 5-year cumulative probability of CNS demyelinating disease or ON recurrence. ResultsDuring the follow-up period (63.1 +/- 46.7 months), 18 patients had experienced other CNS demyelinating attacks, and the 5-year cumulative probability was 14.0 +/- 3.6%. Involvement of the extraorbital optic nerve or optic chiasm and asymptomatic lesions on the brain or spinal MRI at initial presentation were significant predictors for CNS demyelinating attack after the first ON. The 5-year cumulative probability of CNS demyelinating attack was 44.4 +/- 24.8% in the AQP4-IgG group, 26.2 +/- 11.4% in the MOG-IgG group, and 8.7 +/- 5.9% in the double-negative group (P=0.416). Thirty-two patients had experienced a recurrence of ON, and the 5-year cumulative probability was 24.6 +/- 4.0%. In the AQP4-IgG group, the 5-year cumulative probability was 83.3 +/- 15.2%, which was significantly higher than in the other groups (P<0.001).ConclusionsA careful and multidisciplinary approach including brain/spinal imaging and antibody assay can help predict further demyelinating attacks in pediatric ON patients.
引用
收藏
页码:1173 / 1183
页数:11
相关论文
共 50 条
  • [31] Demyelinating optic neuritis presenting as a clinically isolated syndrome
    Holdeman, Nicky R.
    Nguyen, Tammy
    Tang, Rosa A.
    OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION, 2012, 83 (01) : 9 - 18
  • [32] New therapeutic perspectives for demyelinating retrobulbar optic neuritis
    B. Currò Dossi
    A. Amadori
    C. Cirafisi
    S. Lorusso
    M. Pasquinelli
    M. G. Piscaglia
    A. Ravasio
    The Italian Journal of Neurological Sciences, 1998, 19 : 45 - 48
  • [33] Development of a predictive model for predicting disability after optic neuritis: a secondary analysis of the Optic Neuritis Treatment Trial
    Wei, Siqian
    Du, Yi
    Luo, Meifeng
    Song, Ruitong
    FRONTIERS IN NEUROLOGY, 2024, 14
  • [34] Neuroprotection and visual function after optic neuritis
    Petzold, Axel
    CURRENT OPINION IN NEUROLOGY, 2017, 30 (01) : 67 - 73
  • [35] Promising recovery biomarkers after first event acute demyelinating optic neuritis
    Klineova, S.
    Kupersmith, M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [36] Predicting the final clinical phenotype after the first attack of optic neuritis
    Sarin, Shlok
    Modak, Nikhil
    Sun, Rongyi
    Subei, Omar
    Serra, Alessandro
    Morgan, Michael
    Abboud, Hesham
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 381
  • [37] Childhood optic neuritis: The pediatric neurologist's perspective
    Cakmakli, Guel
    Kurne, Asli
    Guven, Alev
    Serdaroglu, Ayse
    Topaloglu, Haluk
    Teber, Serap
    Anlar, Banu
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2009, 13 (05) : 452 - 457
  • [38] Optic neuritis after infliximab therapy
    Faillace, Cesar
    Maltez de Almeida, Joao Ricardo
    de Carvalho, Jozelio Freire
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (04) : 1101 - 1103
  • [39] Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients
    Deschamps, R.
    Lecler, A.
    Lamirel, C.
    Aboab, J.
    Gueguen, A.
    Bensa, C.
    Vignal, C.
    Gout, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (06) : 875 - 879
  • [40] Reply to Pediatric optic neuritis: Points to ponder
    Khadse, Rutika
    Ravindran, Meenakshi
    Pawar, Neelam
    Maharajan, Padmavathy
    Rengappa, Ramakrishnan
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2017, 65 (11) : 1267 - 1268